Business Wire

smartwater Announces Zendaya as Newest Global Brand Ambassador

21.6.2022 16:41:00 EEST | Business Wire | Press release

Share

smartwater is taking hydration to new heights this summer and today announces its newest global brand ambassador, Zendaya. A champion of artistry and originality, acclaimed actor and performer Zendaya is pioneering new ways to live a more purposeful life. As smartwater’s global ambassador, Zendaya will appear in a series of new creative from the brand that celebrates those who are defining ‘smart’ on their own terms and will support community water programs that will directly impact thousands of women.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005427/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Courtesy of The Coca-Cola Company

“We could not be more thrilled to have Zendaya join smartwater as the newest face of our brand,” said Matrona Filippou, Global Category President, Hydration, Sports, Tea & Coffee, The Coca-Cola Company. “A global icon and cultural force, Zendaya isn’t afraid to be true to herself, and that’s what makes her the perfect addition to the smartwater family.”

Created in partnership with VMLY&R and WPP/OpenX, the campaign creative will begin rolling out in the U.S. from June 21 across television, audio, social and streaming channels, with global markets to follow. The campaign celebrates those who keep it smart, whatever the choice, and aren’t afraid to free themselves from the restraints of convention.

“I’m very excited to begin this new relationship with smartwater,” said Zendaya, smartwater Global Brand Ambassador. “We all know how important it is to stay hydrated and smartwater is my go-to source no matter what I am doing throughout the day.”

As the face of the brand’s newest campaign, Zendaya will work with smartwater to support community water quality and access improvements in various cities around the world, starting with Zendaya’s hometown of Oakland, California, by partnering with the Global Water Challenge (GWC) – a coalition of leading organizations collaborating to achieve universal access to clean drinking water. In the U.S. alone, 2.2 million people have no water at home and 44 million Americans are served by water systems that don't function optimally.

Together, smartwater, GWC and Zendaya are launching the smart solutions: global water challenge, which will invite local organizations to apply for grant funding to GWC’s women for water action platform that uplifts women and their communities through the power of clean water access. These efforts build on more than a decade of investments in clean water access around the world from The Coca-Cola Company which have reached more than 18.5 million people since 2010. GWC’s work has proven that with access to clean water, people, especially women and girls, are healthier, safer, educated and employed.

“Our organization doesn’t operate without the support of our purpose-driven partners, and we are grateful to have smartwater and Zendaya on board to help ensure communities in need have more access to clean water,” says Monica Ellis, CEO of Global Water Challenge. “With the smart solutions: global water challenge, we’ll specifically work to address community water access, improving and protecting water quality, and economic empowerment opportunities through water.”

For more information about smartwater, visit smartwater.com. For more information about the Global Water Challenge and the smart solutions: global water challenge, visit www.globalwaterchallenge.org.

About The Coca-Cola Company

The Coca-Cola Company (NYSE: KO) is a total beverage company with products sold in more than 200 countries and territories. Our company’s purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categories worldwide. Our portfolio of sparkling soft drink brands includes Coca-Cola, Sprite and Fanta. Our hydration, sports, coffee and tea brands include Dasani, smartwater, vitaminwater, Topo Chico, BODYARMOR, Powerade, Costa, Georgia, Gold Peak and Ayataka. Our nutrition, juice, dairy and plant-based beverage brands include Minute Maid, Simply, innocent, Del Valle, fairlife and AdeS. We’re constantly transforming our portfolio, from reducing sugar in our drinks to bringing innovative new products to market. We seek to positively impact people’s lives, communities and the planet through water replenishment, packaging recycling, sustainable sourcing practices and carbon emissions reductions across our value chain. Together with our bottling partners, we employ more than 700,000 people, helping bring economic opportunity to local communities worldwide. Learn more at www.coca-colacompany.com and follow us on Twitter, Instagram, Facebook and LinkedIn.

About The Global Water Challenge

Global Water Challenge (GWC) is a coalition of leading organizations deploying expertise and networks to achieve universal access to safe and affordable drinking water, sanitation, and hygiene (WASH) in communities around the world. Since 2006, GWC has positively impacted more than 2 million people across Africa, the Americas and Asia with clean water access and its campaigns, tools, data and best practices reach millions more. In collaboration with multi-sector partners, GWC engages for action – catalyzing financial resources and driving innovative programming for sustainable, local solutions. GWC established the women for water platform to mobilize collective action for clean water access for every woman and her community. Currently scaling impact in 27 countries, women for water measurably contributes to economic empowerment outcomes while raising awareness for this important issue. For more information, please visit globalwaterchallenge.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media: press@coca-cola.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye